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OPA1 Deficiency Associated with Increased Autophagy
in Retinal Ganglion Cells in a Murine Model of
Dominant Optic Atrophy
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PURPOSE. To examine retinal ganglion cell (RGC) and axonal
abnormalities in an ENU-induced mutant mouse carrying a
protein-truncating nonsense mutation in OPA1. Mutations in
the OPA1 gene cause autosomal dominant optic atrophy
(ADOA) in which loss of RGCs followed by myelin degenera-
tion in the optic nerve leads to progressive decrease in visual
acuity.
METHODS. Ultrastructure of the optic nerve was examined in
heterozygous mutants and wild-type littermate controls at 6, 9,
and 24 months using electron microscopy. The RGC layer was
examined at 6 and 24 months.
RESULTS. There was an increase in the number of autophago-
somes in the RGC layer in heterozygous mutants compared
with wild type at 24 months. Signs of optic nerve degener-
ation were seen as early as 9 months in Opa1/ mice, with
more severe degeneration by 24 months. By 24 months,
degeneration of axons was also seen in control mice. Num-
bers of opaque mitochondria in the Opa1/ mice increased
at 6 and 24 months, possibly representing an increase in the
density of cristae to fulfill the energy requirements of
the axon. In addition, mitochondria with vesiculation of the
inner membranes, similar to the mutant mitochondria de-
scribed in a mouse model of Charcot-Marie-Tooth type 2A,
were observed.
CONCLUSIONS. Mutations in OPA1 cause pathologic changes to
optic nerve axons that are similar to, but occur earlier than,
age-related degeneration. Increased autophagy is likely to re-
sult from an increase in abnormal mitochondria and could be
one mechanism contributing to RGC loss and subsequent optic
atrophy seen in ADOA. (Invest Ophthalmol Vis Sci. 2009;50:
2567–2571) DOI:10.1167/iovs.08-2913
Autosomal dominant optic atrophy (ADOA)
1 is the most
common form of primary inherited optic neuropathy; on-
set generally occurs in early childhood.2 The disease is char-
acterized by a progressive decrease in visual acuity, color
vision defects, loss of sensitivity in the central visual field, and
temporal optic nerve pallor.3 Pathologic examination has
shown that there is a reduction in the number of retinal
ganglion cells (RGCs), particularly those in the macular region,
and loss of myelin in the optic nerve, suggesting that the
etiology of the disease is degeneration of the RGCs with as-
cending optic atrophy.4,5
It has previously been shown that mutations in the OPA1
gene cause ADOA.6,7 OPA1 is a mitochondrial protein that is
localized to the inner membrane8 and, in conjunction with
mitofusins Mfn1 and Mfn2, plays a major role in mitochondrial
fusion.9,10 A balance between fission and fusion is essential for
maintaining the integrity of the mitochondrial network. Down-
regulation of OPA1 results in fragmentation of the mitochon-
drial network, dissipation of the mitochondrial membrane po-
tential, disorganization of the cristae, and release of
cytochrome c, followed by caspase-dependent apoptotic nu-
clear events.11
We have recently generated an ENU-induced mutant mouse
carrying a protein-truncating nonsense mutation in opa1,
which is a valuable tool for investigating the pathophysiology
of ADOA. In this model, the heterozygous mutant mice dem-
onstrated visual function impairment and degeneration of the
optic nerve.12 In addition, fibroblasts from the adult heterozy-
gous mutant mice showed an increase in mitochondrial fission
and fragmentation. The onset of optic nerve degeneration was
slow, with the first abnormalities appearing at 9 months and
becoming more prominent by 18 months.
The aim of this study was to determine the degree of axonal
and retinal ganglion cell pathology in heterozygous Opa1 mice
to explore potential mechanisms for neurodegeneration. In
view of the observation that visual loss is delayed in the mice,
as in patients with ADOA, we studied mice up to 24 months of
age and compared the morphologic changes with those seen in
the normal aging process.
MATERIALS AND METHODS
Generation of Mice
The genotype analysis and breeding strategy for generation of the
heterozygous Opa1mice have been described in detail elsewhere.12 In
brief, sperm from C3H males were used (in vitro fertilization with
C57Bl/6J females) to generate heterozygous hybrid Opa1/
“founders” (the B6; C3-Opa1Q258X mouse line). These founder mice
were then crossed with C57Bl/6JCrl mice (Charles River, East Lothian,
UK) to move the mutation to a C57Bl/6JCrl background. Polymerase
chain reaction of tail DNA was used to distinguish wild-type and
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heterozygous mice. All tested Opa1/ and Opa1/ mice were ho-
mozygous wild-type for the rdl allele.
All experiments were approved by the animal ethics committee
and were conducted in accordance with the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research and the Home
Office Animals in Scientific Procedures Act of 1985.
Electron Microscopy
Three Opa1/ mice and three littermate wild-type controls were
examined at 6 months, and five Opa1/ mice and six littermate
controls were examined at 24 months. The mice were killed by lethal
intraperitoneal injection of phenobarbitone and were perfusion fixed
with a mixture of 4% paraformaldehyde and 5% glutaraldehyde in
cacodylate buffer. The eye was dissected out, and the optic nerve and
small pieces of the retina were removed. Optic nerves were also
available from three Opa1/ and three littermate controls at 9
months, though these samples were immersion rather than perfusion
fixed. All samples were postfixed in osmium tetroxide, dehydrated in
acetone, and embedded in epoxy resin.
Optic Nerve
Transverse ultrathin sections (approximately 90 nm) were taken from
the retinal end of the optic nerve, with care taken to avoid the lamina
cribosa. Sections were placed on copper grids, stained with uranyl
acetate and lead citrate, and examined under a transmission electron
microscope (CM100; Philips, Eindhoven, Netherlands).
Fifteen systematically sampled random images of each optic nerve
were taken at a magnification of 7900 for the analysis of axonal
degeneration. An unbiased counting frame was superimposed on each
image with image analysis software (Image Pro 6.2; Media Cybernetics,
Bethesda, MD), and the number of axons within the frame was
counted. The number of abnormal axons was also counted, with
abnormalities classified as “watery” degeneration, “dark” degeneration,
myelin clumping with redundant loops of myelin, or demyelination
(Fig. 1). The number of abnormal axons in each classification was
expressed as a percentage of the total number of axons. All axons were
classified by a single masked observer (VH). The images were also used
to estimate the number of axons per area of optic nerve to determine
whether there was any axonal loss.
Another 15 images were taken at a higher magnification (13,500)
for analysis of mitochondrial morphology. Mitochondria were classi-
fied as either clear or opaque, depending on the electron density of the
mitochondrial matrix (Fig. 2), and were expressed as a percentage of
the total number of mitochondria analyzed. Any abnormal-appearing
mitochondria were noted. All mitochondria were classified by a single
masked observer (KW).
Retina
Ultrathin sections were taken through the tissue such that all the layers
of the retina could be distinguished. Three blocks of retina were
sectioned from each animal. On average, 45 systematically sampled
random images at a magnification of 4600 were taken of the retinal
FIGURE 1. Electron micrographs of
optic nerve axons from 24-month-old
mice. Axon abnormalities were clas-
sified as (A) watery degeneration (as-
terisk), (B) dark degeneration (aster-
isk), (C) myelin clumping (arrow),
and (D) demyelination. Areas of nor-
mal optic nerve from 24-month-old
(E) and 6-month-old (F) mice.
FIGURE 2. Electron micrographs of
optic nerve axons from 24-month-old
mice. Mitochondria were classified
as (A) clear or (B) opaque. (C) Occa-
sional aberrant mitochondria with
vesiculation of the inner membrane
were seen in Opa1/ mice.
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ganglion cell layer in each mouse. Autophagosomes were observed in
the ganglion cell layer and the surrounding axons. These were counted
and expressed as number per unit area. An autophagosome was de-
fined as a double membrane-bound structure that might or might not
be fused with a lysosome (Fig. 3A).
Statistical Analysis
Analysis was conducted with statistical analysis software (SPSS 11.0;
SPSS Inc., Chicago, IL). Comparisons between groups were performed
with Student’s t-test or ANOVA. Two-tailed P  0.05 was considered
statistically significant.
RESULTS
Optic Nerve
The quantification of structural changes seen in the optic nerve
axons is illustrated in Figure 4. At 6 months, there were no
differences in the structure of the axons between Opa1/
FIGURE 4. Graphs showing quantification of structural changes in the optic nerve axons at 6, 9 and 24 months in Opa1/ and Opa1/ mice.
There were no differences in axonal structure between Opa1/ and Opa1/ mice at 6 months. At 9 months, there was evidence of watery and
dark degeneration in the Opa1/ mice, but this did not reach statistical significance. At 24 months, there was a significant increase in the
percentage of axons with disorganized myelin (clumping) in the Opa1/ compared with wild-type controls (P 0.037). All types of degeneration
were significantly increased with age in Opa1/ and Opa1/ mice, and there was a significant reduction in the number of axons per area optic
nerve, indicating axonal loss. There were increased numbers of opaque mitochondria in Opa1/ compared with wild-type controls at 6 (P 
0.027) and 24 (P  0.004) months. *Significant differences between Opa1/ and Opa1/. #Age-related significant differences.
FIGURE 3. (A) Electron micro-
graph of early- and late-stage au-
tophagy in retinal ganglion cell
layer from a 24-month-old mouse.
In the earlier stage, the double-
membrane bound structure (ar-
row) is fusing with a lysosome
(arrowhead). At the later stage
(asterisk), fusion with the lyso-
some has taken place, and the
structure is undergoing proteoly-
sis. (B) Graph showing the num-
bers of autophagosomes per unit
area of the retinal ganglion cell
layer in Opa1/ and Opa1/
mice. At 6 months, there was
no difference. At 24 months,
there was a significant increase in
autophagosomes in the Opa1/
mice compared with wild-type
controls (P  0.016). There was
a significant reduction in the
number of autophagosomes with age in the wild-type controls (P  0.001). *Significant differences between Opa1/ and Opa1/
mice. #Significant differences between 6 and 24 months.
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mice and littermate controls (Figs. 4A–D). At 9 months, the
Opa1/ mice were beginning to show evidence of watery
and dark degeneration compared with littermate controls
(Figs. 4A, B), though these differences did not reach statistical
significance (P  0.06, P  0.08, respectively). At 24 months,
Opa1/ mice had a significantly higher percentage of axons
with disorganized myelin (clumping) than did littermate con-
trols (3.28%  1.60% vs. 1.62%  0.45%; P  0.037; Fig. 4C).
There was no difference in the number of axons per area of
optic nerve between Opa1/ and Opa1/ mice at 6, 9, and
24 months (Fig. 4E).
Mitochondria with clear matrix and opaque matrix were
found in Opa1/ and Opa1/ mice. However, the percent-
age of opaque mitochondria was significantly increased in the
Opa1/mice at 6 and 24 months (45.58% 5.60% vs. 28.70%
 0.66% [P 0.027] and 47.43% 18.14% vs. 15.25% 9.24%
[P  0.004], respectively; Fig. 4F). Some mitochondria in the
optic nerves of 24-month-old Opa1/ mice had structural
abnormalities and vesiculation of the inner membranes (Fig.
2C).
The structural abnormalities of the optic nerve axons were
not restricted to the Opa1/ mice. Opa1/ mice also un-
derwent age-related degeneration of the axons. With increas-
ing age, there was a significant increase in the percentage of
axons with watery degeneration (Fig. 4A; P  0.008) and
myelin clumping (Fig. 4C; P  0.013). At 24 months, two
Opa1/ mice and one Opa1/ mouse had extensive demy-
elination of the optic nerve. Opa1/ and Opa1/ mice
experienced significant reductions in the number of axons per
area of optic nerve with increasing age (Fig. 4E; P  0.009 and
P  0.002, respectively) indicating age-related axonal loss.
Retina
Almost all the mitochondria in the RGCs had clear morphology,
though there was an occasional mutant mitochondrion in the
24-month-old Opa1/ mice, as seen in the optic nerve axons.
At 6 months, there was no difference in the number of
autophagosomes in the RGCs and surrounding axons between
Opa1/ and Opa1/. At 24 months, however, there were
significantly more autophagosomes in the Opa1/ mice than
in the Opa1/ mice (4.25  1.38 vs. 2.57  0.17 m2; P 
0.016; Fig. 3B). The number of autophagosomes in the 24-
month-old Opa1/ mice was significantly lower than in the
6-month-old control mice (P  0.001). There were no statisti-
cally significant age-related differences in the Opa1/ mice.
DISCUSSION
In this study, we describe structural abnormalities in the optic
nerve and the RGC layer of an Opa1/ mouse model of
ADOA. We previously published data showing abnormalities in
the myelination of the optic nerve in 9- and 18-month-old
Opa1/mice,12 and our data here confirm that this is the case
up to 24 months of age.
Two types of axonal degeneration have been described in
the literature.13,14 One is dark degeneration, in which the
axons have a dense axoplasm possibly because of neurofila-
ment aggregation,15 and the other is watery degeneration, in
which the axoplasm either is empty or is filled with an amor-
phous granular material. Both types of degeneration were seen
in the Opa1/ and Opa1/ mice, though watery degenera-
tion was more prominent. The age-related changes seen in the
control mice made it difficult to remove structural abnormali-
ties caused by the OPA1 mutation and those caused by the
aging process. However, we hypothesized that from the time
abnormalities appear in the Opa1/mice, the OPA1mutation
results in premature aging of the optic nerve, and that control
mice might eventually catch-up with Opa1/ mice in axonal
degeneration.
The age-related changes seen in the optic nerves of our
control mice are similar to those reported in the optic nerves
of rhesus monkeys,16 in which the most prominent changes
were axonal degeneration (both dark and watery) and reduced
numbers of nerve fibers. However, the extensive demyelina-
tion found in two of our controls and in one Opa1/ mouse
was unexpected and not paralleled by similar levels of demy-
elination in the optic nerves of humans17 or monkeys.16
The presence of two populations of mitochondria (clear
and opaque) in optic nerve axons has been observed recently
by our group in an Opa3 mutant mouse model of Costeff
syndrome in humans.18 However, given that both types are
present in Opa1/ and Opa1/ mice (though the opaque
type is more prevalent in Opa1/ mice), they may simply
represent an increase in the density of cristae to fulfill the
energy requirements of the axon.
Perhaps of more relevance was the observation that some
mitochondria in the older Opa1/ mice had an abnormal
cristae structure similar to that of mutant mitochondria de-
scribed in a mouse model of Charcot-Marie-Tooth type 2A.19
This neurodegenerative disease is caused by mutations in the
mitochondrial fusion gene Mfn2.20 Mfn2 is one of the three
GTPases involved in mitochondrial fusion.10 The others are
Mfn1 and OPA1.9 Thus, it is highly feasible that mutations in
OPA1 could cause morphologic changes to the mitochondria
similar to those seen with mutations in Mfn2.
We also looked at the structure of the RGCs, and, though a
few mitochondria had abnormal cristae organization, the most
prominent feature of the RGCs and the surrounding axons was
the presence of several double membrane-bound structures
that were identified as autophagosomes.21 Although biomark-
ers have been used to identify autophagosomes, this method is
compromised because of a lack of differential gene expression;
transmission electron microscopy remains the most accurate
way to evaluate autophagy in tissue.22 Even so, electron mi-
croscopy is not without its limitations, and it is possible to
overestimate autophagy by misidentifying other vacuoles as
autophagic. In our study, we counted only structures that were
bound by a double membrane or were obviously fusing with a
lysosome. We did not try to count late-stage autophagic vacu-
oles because these cannot be distinguished from heterophagic
vacuoles. Given that large numbers of nonspecific vacuoles
were present in the cells, we feel we were more likely to have
underestimated rather than overestimated the level of autoph-
agy occurring in these cells.
Autophagy is a cellular pathway for the clearance of pro-
teins and organelles; therefore, some degree of autophagy is
necessary to maintain normal cellular homeostasis.23 Different
tissues require different levels of autophagy, but it is particu-
larly important in quiescent cells such as neurons.24 Thus, it
was not surprising that autophagosomes were observed in the
RGCs of our mice. In addition, the reduction in the number of
autophagosomes in the older control mice is consistent with
the published data on autophagy decline with age.25,26
What is even more interesting is that there were more
Opa1/ mice than littermate controls. In addition, there was
no age-related decline in autophagy in the Opa1/ mice.
Increased numbers of autophagosomes are a feature in a num-
ber of neurologic diseases, but the question is whether this is
a result of the increased formation of autophagosomes or of the
decreased lysis and breakdown of the autophagosomes.27 The
large amounts of nonspecific vacuoles and cytoplasmic debris
that were also present suggest that the formation of autopha-
gosomes was increased in this study.
Why then would a mutation in OPA1 cause increased auto-
phagy? Downregulation of OPA1 results in a loss of the mito-
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chondrial membrane potential and, thus, the formation of
depolarized mitochondria, which are dysfunctional and must
be “rescued” or eliminated. It has been suggested that mito-
chondrial fusion is a mechanism by which depolarized mito-
chondria are recovered,28 whereas autophagy has been shown
to target depolarized mitochondria for digestion and elimina-
tion.29,30 If fusion and autophagy compete with each other for
depolarized mitochondria in our Opa1/ mouse model, in
which mitochondrial fusion is impaired, autophagy is more
likely to be the winner. This hypothesis is supported by a
recent study in which overexpression of OPA1 decreased mi-
tochondrial autophagy.31
It could be argued that this increased autophagy would
maintain cellular homeostasis and have no detrimental effect
on the cell. However, because RGC loss is the primary patho-
logic characteristic of ADOA, it is possible that the autophagic
process becomes overloaded, resulting in an accumulation of
defective mitochondria, the release of cytochrome c, and ulti-
mately the apoptosis of RGCs.
In conclusion, we have shown that mutations in OPA1
cause pathologic changes to optic nerve axons that are similar
to, but occur earlier than, age-related degeneration. In addi-
tion, we suggest that increased autophagy could be one mech-
anism contributing to RGC loss and the subsequent optic
atrophy seen in ADOA.
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